Tomatidine Relieves Neuronal Damage in Spinal Cord Injury by Inhibiting the Inflammatory Responses and Apoptosis Through Blocking the NF-κB/CXCL10 Pathway Activation

Overview

Journal Front Pharmacol

Date 2024 Dec 27

PMID 39726790

Authors

Xu Wang

Wei Huang

Hao Sun

Hua Wang

Dongxu Wang

Yongxiang Wang

Affiliations

Soon will be listed here.

Abstract

Background: Spinal cord injury (SCI) is a neurological disease characterized by high disability and mortality rates. Tomatidine, a natural steroid alkaloid, has been evidenced to have neuroprotective properties. However, the underlying mechanisms of tomatidine in treating SCI remain ambiguous. This study aimed to illustrate the molecular mechanisms of tomatidine in modulating the inflammatory response and promoting functional rehabilitation after SCI.

Methods: Sprague-Dawley (SD) rats were used to construct an SCI model and were intraperitoneally injected with tomatidine (5, 10, or 20 mg/kg) for 7 days, followed by treatment with the nuclear factor-κB (NF-κB) pathway agonist (PMA). In addition, lipopolysaccharide (LPS)-induced PC-12 cells were used to establish an SCI cell model and were stimulated with tomatidine, PMA, or a CXCL10 inhibitor. The pathophysiological changes and neurological function were evaluated using blood-brain barrier (BBB) scoring, water content determination, hematoxylin and eosin (H&E) staining, and TUNEL assay. Levels of inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, were measured. Cell proliferation, apoptosis, and the expression of C-X-C motif chemokine ligand 10 (CXCL10) were determined. Moreover, the expression of cleaved-caspase 3, caspase 3, CXCL10, p-p65, and p65 were analyzed.

Results: Our data revealed that tomatidine promoted neuronal damage recovery, reduced histopathological changes, elevated cell proliferation, and inhibited the apoptosis and inflammatory factor levels in spinal cord tissues and LPS-induced PC-12 cells. Moreover, tomatidine decreased the expression of CXCL10 and , which was accompanied by the regulation of the NF-κB pathway. However, the NF-κB pathway agonist PMA reversed the protective effect of tomatidine . PMA also enhanced the CXCL10 expression and stimulated the activation of the NF-κB pathway, as demonstrated by the upregulation of phosphorylated p65. The CXCL10 inhibitor had effects similar to tomatidine on cleaved-caspase 3 expression, CXCL10 expression, and the NF-κB pathway.

Conclusion: Tomatidine can alleviate neuronal damage in SCI by inhibiting apoptosis and inflammation through the NF-κB/CXCL10 pathway. Our findings provide a novel therapeutic target and candidate for the treatment of SCI.

References

Nie M, Li H, Liu P, Dang P . HMBOX1 attenuates LPS-induced periodontal ligament stem cell injury by inhibiting CXCL10 expression through the NF-κB signaling pathway. Exp Ther Med. 2022; 23(3):224. PMC: 8812104. DOI: 10.3892/etm.2022.11148. View

Venkatesh K, Ghosh S, Mullick M, Manivasagam G, Sen D . Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications. Cell Tissue Res. 2019; 377(2):125-151. DOI: 10.1007/s00441-019-03039-1. View

Doron H, Amer M, Ershaid N, Blazquez R, Shani O, Lahav T . Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis. Cell Rep. 2019; 28(7):1785-1798.e6. DOI: 10.1016/j.celrep.2019.07.033. View

Jeon S, Kim M . Tomatidine inhibits cell invasion through the negative modulation of gelatinase and inactivation of p38 and ERK. Chem Biol Interact. 2019; 313:108826. DOI: 10.1016/j.cbi.2019.108826. View

Hong S, Kang N, Kim O, Hong S, Park J, Kim J . EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer. Cancers (Basel). 2023; 15(1). PMC: 9817815. DOI: 10.3390/cancers15010124. View

Yu H, Lin L, Zhang Z, Zhang H, Hu H . Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020; 5(1):209. PMC: 7506548. DOI: 10.1038/s41392-020-00312-6. View

Ozga A, Chow M, Lopes M, Servis R, Di Pilato M, Dehio P . CXCL10 chemokine regulates heterogeneity of the CD8 T cell response and viral set point during chronic infection. Immunity. 2021; 55(1):82-97.e8. PMC: 8755631. DOI: 10.1016/j.immuni.2021.11.002. View

Khaboushan A, Pahlevan-Fallahy M, Shobeiri P, Teixeira A, Rezaei N . Cytokines and chemokines profile in encephalitis patients: A meta-analysis. PLoS One. 2022; 17(9):e0273920. PMC: 9436077. DOI: 10.1371/journal.pone.0273920. View

Neinast M, Murashige D, Arany Z . Branched Chain Amino Acids. Annu Rev Physiol. 2018; 81:139-164. PMC: 6536377. DOI: 10.1146/annurev-physiol-020518-114455. View

10.

Mordillo-Mateos L, Sanchez-Ramos A, Coperchini F, Bustos-Guadamillas I, Alonso-Bonilla C, Vargas-Baquero E . Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage. Spinal Cord. 2019; 57(11):953-959. DOI: 10.1038/s41393-019-0311-3. View

11.

Nazari A, Ahmadi Z, Hassanshahi G, Abbasifard M, Taghipour Z, Khanamani Falahati-Pour S . Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review. Oman Med J. 2020; 35(2):e103. PMC: 7064791. DOI: 10.5001/omj.2020.21. View

12.

Duan R, Qu M, Yuan Y, Lin M, Liu T, Huang W . Clinical Benefit of Rehabilitation Training in Spinal Cord Injury: A Systematic Review and Meta-Analysis. Spine (Phila Pa 1976). 2021; 46(6):E398-E410. DOI: 10.1097/BRS.0000000000003789. View

13.

Qiao X, Zhang W, Zhao W . Role of CXCL10 in Spinal Cord Injury. Int J Med Sci. 2022; 19(14):2058-2070. PMC: 9724238. DOI: 10.7150/ijms.76694. View

14.

Ma H, Wang C, Han L, Kong F, Liu Z, Zhang B . Tofacitinib Promotes Functional Recovery after Spinal Cord Injury by Regulating Microglial Polarization via JAK/STAT Signaling Pathway. Int J Biol Sci. 2023; 19(15):4865-4882. PMC: 10539697. DOI: 10.7150/ijbs.84564. View

15.

Chu X, Yu T, Huang X, Xi Y, Ni B, Zhang R . Tomatidine suppresses inflammation in primary articular chondrocytes and attenuates cartilage degradation in osteoarthritic rats. Aging (Albany NY). 2020; 12(13):12799-12811. PMC: 7377830. DOI: 10.18632/aging.103222. View

16.

Zhao H, Mei X, Yang D, Tu G . Resveratrol inhibits inflammation after spinal cord injury via SIRT-1/NF-κB signaling pathway. Neurosci Lett. 2021; 762:136151. DOI: 10.1016/j.neulet.2021.136151. View

17.

Yu T, Wu Q, You X, Zhou H, Xu S, He W . Tomatidine Alleviates Osteoporosis by Downregulation of p53. Med Sci Monit. 2020; 26:e923996. PMC: 7191956. DOI: 10.12659/MSM.923996. View

18.

He N, Zheng X, He T, Shen G, Wang K, Hu J . MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice. CNS Neurol Disord Drug Targets. 2020; 20(3):298-308. DOI: 10.2174/1871527319666201005170659. View

19.

Alvarez-Perez B, Homs J, Bosch-Mola M, Puig T, Reina F, Verdu E . Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice. Eur J Pain. 2015; 20(3):341-52. DOI: 10.1002/ejp.722. View

20.

Zhang N, Wei G, Ye J, Yang L, Hong Y, Liu G . Effect of curcumin on acute spinal cord injury in mice via inhibition of inflammation and TAK1 pathway. Pharmacol Rep. 2017; 69(5):1001-1006. DOI: 10.1016/j.pharep.2017.02.012. View